New research into genetic mutation's role in breast cancer could open new treatment options for lunch cancer, according to a MSU scientist
New research into a genetic mutation’s role in breast cancer could open new treatment options for lung cancer, according to a Michigan State University scientist.
On June 22, more than 2,000 cyclists rode through scenic West Michigan for the seventh annual MSU Gran Fondo, a timed, non-competitive event, that has raised more than $1 million toward skin cancer awareness, prevention and research within the College of Human Medicine.
Italian for “big ride,” people of all ages and skill levels participated in the 12-mile Family Ride or longer distances on the 25, 40 or 80 routes. Some participants were avid cyclists with a passion for these types of “mass-start” events, while others rode to honor a loved one or recognize their own battle with skin cancer.
JACQUELINE SETAS, a recent Spartan graduate, came to Michigan State University on a golf scholarship. During her time on the MSU Women's Golf Team, Setas began noticing her body slowly breaking down and eventually was diagnosed with Stage 2 Hodgkin's Lymphoma.
Scientists are using a lot of genomic data to identify medical issues sooner in patients, but they’re also using it to assist their scientific counterparts in researching diseases better.
In a new study, Michigan State University researchers are analyzing large volumes of data, often referred to as big data, to determine better research models to fight the spread of breast cancer and test potential drugs. Current models used in the lab frequently involve culturing cells on flat dishes, or cell lines, to model tumor growth in patients.